TETRAPHASE PHARMACEUTICALS INC Uncategorized Contracts & Agreements

27 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Support Agreement, dated June 24, 2020, by and among the Parent, the Purchaser and the stockholder named therein
TETRAPHASE PHARMACEUTICALS INC
Pharmaceuticals
2020
Form of Contingent Value Rights Agreement, by and between the Parent and the Rights Agent
TETRAPHASE PHARMACEUTICALS INC
Pharmaceuticals
DE
2020
Form of Support Agreement, dated June 4, 2020, by and among the Parent, the Purchaser and the stockholder named therein
TETRAPHASE PHARMACEUTICALS INC
Pharmaceuticals
2020
Form of Contingent Value Rights Agreement, by and between the Parent and the Rights Agent
TETRAPHASE PHARMACEUTICALS INC
Pharmaceuticals
DE
2020
Form of Contingent Value Rights Agreement, by and between AcelRx and the Rights Agent
TETRAPHASE PHARMACEUTICALS INC
Pharmaceuticals
DE
2020
Form of Contingent Value Rights Agreement, by and between AcelRx and the Rights Agent
TETRAPHASE PHARMACEUTICALS INC
Pharmaceuticals
DE
2020
Co-Promotion Agreement, dated March 15, 2020, by and between the Parent and the Company
TETRAPHASE PHARMACEUTICALS INC
Pharmaceuticals
NY
2020
Form of Contingent Value Rights Agreement, by and between the Parent and the Rights Agent
TETRAPHASE PHARMACEUTICALS INC
Pharmaceuticals
DE
2020
Description of Registrants Securities
TETRAPHASE PHARMACEUTICALS INC
Pharmaceuticals
2020
Payoff Letter, entered into as of August 30, 2019, by and among Tetraphase Pharmaceuticals, Inc., Solar Capital Ltd., as collateral agent and lender, and the other lenders named...
TETRAPHASE PHARMACEUTICALS INC
Pharmaceuticals
2019
Offer letter, dated as of July 31, 2019, by and between the Registrant and Larry Edwards
TETRAPHASE PHARMACEUTICALS INC
Pharmaceuticals
MA
2019
Offer letter, dated as of March 1, 2018, by and between the Registrant and Larry Edwards
TETRAPHASE PHARMACEUTICALS INC
Pharmaceuticals
MA
2018
Amendment, dated as of December 5, 2017, by and between the Registrant and the President and Fellows of Harvard College, as amended
TETRAPHASE PHARMACEUTICALS INC
Pharmaceuticals
2018
Offer letter, dated as of December 27, 2017, by and between the Registrant and Larry Tsai
TETRAPHASE PHARMACEUTICALS INC
Pharmaceuticals
MA
2018
Offer Letter, dated as of September 21, 2017, by and between the Registrant and Kamalam Unninayar
TETRAPHASE PHARMACEUTICALS INC
Pharmaceuticals
MA
2017
- 2 -
TETRAPHASE PHARMACEUTICALS INC
Pharmaceuticals
MA
2015
AMENDMENT TO OFFER LETTER
TETRAPHASE PHARMACEUTICALS INC
Pharmaceuticals
MA
2014
THIRD AMENDMENT TO OFFER LETTER
TETRAPHASE PHARMACEUTICALS INC
Pharmaceuticals
MA
2014
SECOND AMENDMENT TO OFFER LETTER
TETRAPHASE PHARMACEUTICALS INC
Pharmaceuticals
MA
2014
LEASEAGREEMENT
TETRAPHASE PHARMACEUTICALS INC
Pharmaceuticals
2014
Additional abbreviations may also be used though not in the above list.
TETRAPHASE PHARMACEUTICALS INC
Pharmaceuticals
2013
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
TETRAPHASE PHARMACEUTICALS INC
Pharmaceuticals
MA
2013
LEASEAGREEMENT
TETRAPHASE PHARMACEUTICALS INC
Pharmaceuticals
2013
Tetraphase Pharmaceuticals, Inc. Confidential
TETRAPHASE PHARMACEUTICALS INC
Pharmaceuticals
MA
2013
TetraphasePharmaceuticals, Inc. Confidential
TETRAPHASE PHARMACEUTICALS INC
Pharmaceuticals
MA
2013
TETRAPHASE PHARMACEUTICALS, INC. August 10, 2006
TETRAPHASE PHARMACEUTICALS INC
Pharmaceuticals
MA
2013
SECOND AMENDED AND RESTATED REGISTRATION RIGHTSAGREEMENT
TETRAPHASE PHARMACEUTICALS INC
Pharmaceuticals
MA
2013